Manager CMC

Are you a proactive positive team player with a flexible mindset, who communicates easily with many different people, and has a passion for contributing to the development of medicines for rare CNS disorders?

Then this might be the perfect job for you!

Vico Therapeutics B.V. is a global Leiden-based biotech company with a focus on developing innovative antisense oligonucleotide therapies for rare neurological disorders (www.vicotx.com).

Our growing team is committed to bringing new therapeutics to those patients who need it most. The company atmosphere is pleasant and informal, contributing to a particularly friendly working environment.
We are currently recruiting for a

Manager CMC

Your key responsibilities and tasks will include, but are not limited to, the following:

  • Overseeing and executing the stability study strategy and coordination
  • Coordinating shipments and inventory management
  • Leading analytical vendor management
  • Supporting the Director Analytical Chemistry with all analytical related activities
  • Supporting the Director CMC with general, day-to-day, CMC activities

Preferred profile:

  • MSc or PhD in analytical chemistry
  • Minimal three years of experience in the biopharmaceutical industry in a CMC role
  • Experience with working in multi-disciplinary teams
  • Experience with stability studies and/or writing of regulatory documents
  • Proactive team player who communicates easily and builds relationships
  • Problem-solving and flexible mindset
  • Fluent in English (both verbal and written)
  • Quality/GMP oriented

What do we offer?

  • Competitive salary, including holiday allowance
  • Performance bonus
  • Possibility for hybrid working with at least 3 days at the office
  • Good pension scheme
  • Travel allowance and work-from-home allowance
  • Laptop
  • Several social activities and drinks

Does this job description sounds appealing to you?

You can mail your resume and motivation letter to Yessica.debrouwer@vicotx.com

We look forward to receiving your application!

Scroll to Top
Leadership
Leadership micah mackison

Leadership

Micah Mackison

Chief Executive Officer
Linkedin icon

Mr. Micah Mackison was appointed CEO of Vico Therapeutics in August 2022. Prior to this role, Micah served as Chief Business Officer and Executive Vice President of Strategy and Corporate Development at Locanabio, an RNA-targeted gene therapy company. At Locanabio, he was instrumental in setting strategy, raising capital and helping build an organization focused on genetic neurological diseases. Prior to Locanabio, Micah held several leadership positions in corporate development and strategy. He served as Senior Vice President, Corporate Development and Strategy at Assembly Biosciences where he led business development efforts. Previously, Micah served as Head of Corporate Strategy and Senior Director, New Ventures at H. Lundbeck A/S, where he was focused on neuroscience. Prior to Lundbeck’s acquisition, he was Director, Corporate Development and M&A at Ovation Pharmaceuticals, a neuroscience-focused company that launched the first product for Huntington’s disease.

Earlier in his career, Micah held financial roles at Eli Lilly and Pfizer. He earned a B.S. in Finance from the Kelley School of Business at Indiana University.